Our Team

We leverage Big Data to save lives.

Experienced, Multidisciplinary Team of Clinicians and AI Scientists

CEO, Co-Founder

Gal Salomon

Prior to founding CLEW, Mr. Salomon founded Sansa Security (formerly Discretix) and led the company as CEO from inception until August 2010. He then served as its active Chairman until the acquisition by ARM. During this time, he was a Venture Partner at Pitango Venture Capital. Prior to founding Discretix, Mr. Salomon served in multiple positions in DSP Communications (NYSE: DSP) and Intel. Mr. Salomon holds a B.Sc. in Electrical Engineering and an MBA.

VP Product, Co-Founder

Avigdor Faians

Mr. Faians brings more than twenty years of experience in design management and system architecture for the networking, communications and consumer electronics markets. He served as CTO of WAN communications at Mindspeed Technologies and VP R&D at Techtium. Mr. Faians holds a B.Sc. in Physics, cum laude, from Ben-Gurion University of the Negev and an Electrical Engineering degree from the Technion – Israel Institute of Technology.

Chief Scientist

Prof. Assaf Zeevi

Prof. Ze’evi is the Vice Dean for Research and the Henry Kravis Professor of Business at the Graduate School of Business, Columbia University. His research is broadly focused on the formulation and analysis of mathematical models of complex systems. Ze’evi received his B.Sc. and M.Sc. (1997) Cum Laude from the Technion – Israel Institute of Technology, and subsequently his Ph.D. (2001) from Stanford University. In 2001, he joined the faculty of the Business School at Columbia University.

VP Clinical Development

Dr. Uri Keler

Responsible for CLEW Medical’s clinical strategy, Dr. Keler’s roles include: clinical goals and guidance for the analytics team, managing all phases of clinical trials and the preparation of research manuscripts for local and international conferences. Prior to attaining his medical degree, Dr. Keler was a Marketing Director at BVR systems, a position he held for 6 years. Dr. Keler is a graduate of Israel Naval Academy and served as a submarine XO. Dr. Keler received his MD from the Tel Aviv University, followed by a surgical residency at Sheba Medical Center in Israel.

VP Human Resources

Osnat Rosenwax

Ms. Rosenwax joined CLEW in 2016, with more than 20 years of human resource management experience. She served as VP Human Resources for Webpals, a position she held since 2012. She has worked as an independent HR consultant in the tech sector, Director of HR at Discretix, HR Manager of PacketLight and a HR specialist at Telrad Networks. Osnat holds a B.A in Sociology and Educational Counseling from Tel Aviv University, and Associates Degrees in Organizational Consulting and Mediation.

VP Business Development, North America

Bruce McCalley

Mr. McCalley brings more than twenty-five years of healthcare sales and marketing experience, along with international experience in over forty countries. Having started his education in Pharmacy at the University of South Carolina in Columbia, Mr. McCalley has a co-authorship in the Journal of Bacteriology with Phillip E. Mirkes, Ph.D. for genetics research funded by the American Cancer Society. Finding his passion for computer science and analytics, he transferred to the Georgia Institute of Technology where he completed his B.S. degree. Mr. McCalley also has an extensive background in high technology startup companies with two, successful IPOs on NASDAQ and four acquisitions.

Medical Director

Dr. Itai Pessach

Dr. Pessach is an Assistant Professor of Pediatrics at the Tel-Aviv University and a Deputy Director at Safra Children’s Hospital, Sheba Medical Center. He is certified in allergy immunology and in pediatric critical care. He has a broad background in basic and clinical research and has published extensively in the fields of pediatric immunology and critical care. Dr. Pessach holds MD and PhD degrees from the Ben-Gurion University and has trained both at Sheba Medical Center and at Children’s Hospital Boston, Harvard Medical School.

VP R&D

Elisha Ben-Zvi

Mr. Elisha Ben-Zvi brings a passion for connecting smart engineers to create innovative products. He has 20 years of experience building large-scale solutions in Big Data, security, and networking at Akamai, Contendo, and SAP. Prior to joining CLEW, Mr. Ben-Zvi served as senior director at Akamai, where he led international engineering, research, and data science teams delivering enterprise and web security products, and took an active part in scaling-up the company’s security business. Mr. Ben-Zvi holds a B.Sc. from the Academic College of Tel Aviv-Jaffa.

Advisory Board

Emory University School of Medicine

James M. Blum, MD

Dr. Blum is an NIH funded investigator and recognized expert in perioperative ARDS. He received national awards from the IARS and SOCCA. He served on several committees at SCCM, USCIITG, and has been an invited lecturer at multiple institutions, USCIITG, SCCM, IARS, and ASA. He is an active reviewer for multiple journals in both anesthesiology and critical care medicine. Blum is recognized as a national leader in critical care. His research focuses on perioperative lung injury and large datasets for outcomes research and waveform analysis.

Email:

Beth Israel Deacones, Boston, MA

Daniel Talmor, MD

Prof. Talmor is Professor of Anesthesia at Harvard Medical School and Chairman for Critical Care Medicine in the Department of Anesthesia, Critical Care, and Pain Medicine at Beth Israel Deaconess Medical Center in Boston. His fields of research include intensive care outcomes and echocardiography in the ICU. He also brings an interest in the application of data and analytics to the improvement of patient outcomes. Dr. Talmor is a graduate of Ben-Gurion University Medical School and has lectured extensively both nationally and internationally on topics relating to anesthesia and critical care.

Brigham & Women, Boston, MA

David Bates, MD

Prof. Bates is Senior Vice President for Quality and Safety and Chief Quality Officer for both the Brigham and Women’s Hospital and the Brigham and Women’s Physicians Organization. He is a practicing general internist who maintains positions at Brigham and Women’s Hospital, Harvard Medical School and Harvard School of Public Health, where he co-directs the Program in Clinical Effectiveness. Prof. Bates is a graduate of Stanford University and the Johns Hopkins School of Medicine.

Assuta Medical Center, Israel

Eran Segal, MD

Dr. Segal is the Director for the department of Anesthesia, Intensive Care and Pain Medicine at Assuta Medical Centers in Israel. Prior to joining Assuta, Dr. Segal was the Director of Critical Care at Sheba Medical Center in Israel.

Tel Aviv Medical Center, Israel

Idit Matot, MD

Prof. Matot is the Chairwoman of the Division of Anesthesia, Critical Care and Pain Medicine at Tel Aviv Medical Center in Israel. She received her M.D from the Hebrew University School of Medicine, Jerusalem and was a senior anesthesiologist for 14 years at Hadassah Medical Center. Her research focus is perioperative outcome (clinical) and liver perfusion and regeneration (experimental).

University of Chicago, Chicago, IL

Michael F. O’Connor, MD

Prof. O’Connor is the Director of Critical Care Medicine at the University of Chicago Medical Center. As an anesthesiologist and intensivist, Dr. O’Connor spent much of the past 23 years working in intensive care units, including the Burn ICU, Surgical ICU, Medical ICU, and Cardiothoracic ICU. His wide range of clinical interests includes improving the performance of alarms in the ICU and predicting decompensation in ward patients. As a leader of the initiative to create ACLS guidelines for the perioperative setting, Dr. O’Connor has authored guidelines as well as multiple books and chapters on various aspects of Critical Care.

Stanford Hospital, Stanford, CA

Ronald Pearl, MD

Prof. Pearl is an anesthesiologist in Palo Alto, California and is affiliated with multiple hospitals in the area, including the Lucile Salter Packard Children’s Hospital at Stanford and Stanford Hospital and Clinics. Dr. Pearl received his medical degree from the University of Chicago Pritzker School of Medicine and has been in practice for 38 years.

Board of Directors

CEO, Co-Founder

Gal Salomon

Prior to founding CLEW, Mr. Salomon founded Sansa Security (formerly Discretix) and led the company as CEO from inception until August 2010. He then served as its active Chairman until the acquisition by ARM. During this time, he was a Venture Partner at Pitango Venture Capital. Prior to founding Discretix, Mr. Salomon served in multiple positions in DSP Communications (NYSE: DSP) and Intel. Mr. Salomon holds a B.Sc. in Electrical Engineering and an MBA.

Barbara Lubash

Barbara Lubash has specialized in healthcare IT and services sectors over her career as a venture investor, operating executive, and professional board member. She is Co-founder and Managing Director of Versant Ventures Funds I-III. Prior to Versant, she was a Venture Partner at Crosspoint Ventures. She is Chair of the Board of the  California Health Care Foundation (CHCF), and serves on boards of RedBrick Health and Advanced ICU Care.  Prior boards include Vantage Oncology (now McKesson), Concerto Health (FKA Fidelis SeniorCare), CodeRyte (observer), Concuity, Cogent (now Cogent/HMG), Titan Health. She has taken a leadership role in her VC sector, founding the CEO conference now known as the HEP Summit, and advised CHCF management in establishing  one of the first health services/IT Program Related (impact) Investment strategies in the U.S.  She was named 2014 Director of the Year by the OC Forum for Corporate Directors, and is a member of the Partners HealthCare (Boston) Innovation Advisory Board. Her earlier operating career includes management roles at Hewlett Packard, Harvard Community Health Plan, Pacific Review Services (div PacifiCare/United), and Private Healthcare Systems (PHCS). Barbara holds a Master’s in Health Policy and Management from Harvard University and a B.S. in Psychology from Tufts University.

Ittai Harel

Ittai Harel is a Managing General Partner at Pitango Venture Capital.
He brings 15 years of operating and management roles experience, and over ten years of experience in venture capitalHis investment focus is on venture stage investments in Tech & Healthcare and includes Digital Health, Health-IT and MedTech.

Before joining Pitango, Ittai headed up Corporate Development at Nektar Therapeutics (NASDAQ: NKTR) and served as Executive Vice President at IDGene Pharmaceuticals.

He also served as Vice President of Business Development at IDEXX Laboratories (NASDAQ: IDXX).

Ittai currently serves on the Board of Directors of I LifeBondDouxMatokEarlySenseMedisafeClew Medical and Vertos Medical, and serves as Chairman of the Board at LifeBond and EarlySense
Ittai holds a B.Sc. in Chemical Engineering and Biotechnology from Ben-Gurion University, and an MBA from the MIT Sloan School of Management.

Lihu Avitov

Lihu brings 17 years of experience in healthcare management. Previously Mr. Avitov  served 3.5 years as Angioslide CEO between 2011-2015.
Prior to Angioslide he served as an EVP at XT Investments ech, one of Israel’s leading private equity firms, heading the healthcare team.

Prior to that, he served as CEO of Naiot Venture Accelerator, and as General Manager of Rimlon, a medical device company in the orthopedics field.
At XT and Naiot he led various investments in innovative healthcare technologies and played an active role in their day-to-day management. In 2007 Mr. Avitov co-founded PainReform. Mr. Avitov holds a bachelor’s degree in Economics and Management, and a master’s degree from the Department of Industrial Engineering and Management at the Technion – Israel Institute of Technology in Haifa, Israel.